FIELD: medicine.
SUBSTANCE: invention can be used for treating cerebral tumours and melanoma. That is ensured by introducing heat shock protein solution 70 inside the tumor which is derived by using a producer strain of Escherichia coli BB 1553, transformed using vector plasmid pMSHsp70 in dosage 0.5 mg of protein. Therapeutic course consists of 5-8 injection through the 1-2 days.
EFFECT: using the given method causes delayed tumour growth in case of administration of the preparation inside the tumor by activating cytotoxic lymphocytes, higher production of gamma-interferon in the body.
1 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING METASTATIC CANCER USING SENDAI VIRUS | 2017 |
|
RU2662916C1 |
| METHOD FOR TREATMENT OF ONCOLOGY DISEASES | 2004 |
|
RU2271831C1 |
| METHOD OF STIMULATING ANTI-TUMOUR ACTIVITY OF CYTOTOXIC EFFECTORS OF IMMUNE SYSTEM | 2010 |
|
RU2429005C1 |
| HYBRID PROTEINS AND PROTEIN CONJUGATES BASED ON HEAT SHOCK PROTEIN-70 (HSP70) AND METHODS FOR USE THEREOF (VERSIONS) | 2012 |
|
RU2685867C2 |
| METHOD OF TREATING ONCOLOGICAL DISEASES | 2008 |
|
RU2379055C1 |
| GENETIC STRUCTURE RBCT70 FOR EXPRESSION OF THE MAIN HUMAN STRESS PROTEIN IN MILK OF TRANSGENIC ANIMALS | 2015 |
|
RU2644663C2 |
| METHOD FOR OBTAINING PREPARATION THAT CONTAINS THE COMPLEX OF HEAT SHOCK PROTEINS 70, 90, 96 ASSOCIATED WITH ANTIGENOUS PEPTIDES | 2005 |
|
RU2287339C1 |
| STRAIN OF Escherichia coli BACTERIA - PRODUCENT OF HEAT SHOCK PROTEIN 70 AND METHOD FOR OBTAINING PREPARATION OF HUMAN HEAT SHOCK PROTEIN | 2013 |
|
RU2564120C2 |
| CEREBRAL CANCER TREATMENT WITH ONCOLYTIC ADENOVIRUS | 2014 |
|
RU2689553C2 |
| VACCINE COMPOSITIONS, METHODS FOR APPLICATION THEREOF IN MELANOMA PREVENTION AND TREATMENT, AND GENETIC CONSTRUCTIONS FOR OBTAINING ACTIVE SUBSTANCES OF COMPOSITION | 2006 |
|
RU2333767C2 |
